Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 38 views
- Tata Motors Eyeing to Acquire Ford’s Factory in India 37 views
- Expect a Fierce Race Between VW and Tesla Says VW CEO 35 views
- Apple to Provide Other Payment Methods in Dating Apps Says Dutch Watchdog 34 views
- China Unveils Maglev Train With a Top Speed of 600 kph 34 views